The EMA intends to update the Guidance concerning Additional Risk Minimisation Measures

Published date22 October 2020
Subject MatterPharmaceutical Industry,Risk Mitigation,European Medicines Agency (EMA),EU,Regulatory Standards,New Guidance
AuthorElisabethann Wright
Law FirmHogan Lovells

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT